Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)
ID: PAR-22-250 • Type: Posted
Opportunity Assistant
Loading
Overview
Category of Funding
Health
Funding Instruments
Grant
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 9/14/22 the National Institutes of Health posted grant opportunity PAR-22-250 for Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional).
The grant will be issued under grant program 93.859 Biomedical Research and Research Training.
Timing
Posted Date
Sept. 14, 2022, 12:00 a.m. EDT
Closing Date
Jan. 30, 2025, 12:00 a.m. EST Past Due
Last Updated
Sept. 21, 2022, 2:31 p.m. EDT
Version
2
Archive Date
March 7, 2025
Eligibility
Eligible Applicants
State governments
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Nonprofits Other Than Institutions of Higher Education
Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
Award Sizing
Ceiling
$1,500,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed
Contacts
Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/pa-files/PAR-22-250.html
Additional Information Site